The role of relative advantage for development of sequencing-based diagnostics for pediatric cancer in low- and middle-income countries
Cancer
.
2024 Jan;130(2):173-178.
doi: 10.1002/cncr.35065.
Epub 2023 Oct 16.
Authors
Anissa Berger
1
,
Stuart Rennie
1
,
Javeria Aijaz
2
,
Liza-Marie Johnson
3
,
Federico Antillon
4
,
Megan C Roberts
5
,
Inam Chitsike
6
,
Joyce Kambugu
7
,
Vaskar Saha
8
,
Nickhill Bhakta
9
,
Arlene M Davis
1
,
Thomas B Alexander
10
11
Affiliations
1
Department of Social Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
2
Department of Pathology, Indus Health and Hospital Network, Karachi, Pakistan.
3
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
4
Unidad Nacional de Oncologia, Guatemala City, Guatemala.
5
Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.
6
University of Zimbabwe, Harare, Zimbabwe.
7
Uganda Cancer Institute, Kampala, Uganda.
8
Tata Translational Cancer Research Center, Kolkata, India.
9
Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
10
Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.
11
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
PMID:
37843081
DOI:
10.1002/cncr.35065
No abstract available
Keywords:
cancer; classification; diagnosis; ethics; health resources; pediatrics.
MeSH terms
Child
Developing Countries*
Humans
Neoplasms* / diagnosis
Neoplasms* / genetics